Tamoxifen Update

The latest on Tamoxifen finds long term data showing the drug's effect of reducing the risk for breast cancer persists even after the drug is stopped have now been published in the February 21 issue of the Journal of the National Cancer Institute.

This is based on analysis of two major breast cancer studies .. one following women for 8 years, the other for 13 years.

Now, an editorial accompanying the publication of the studies says, "The long-term results of these 2 important trials reinforce the notion that tamoxifen is effective with an acceptable safety profile in reducing the risks of — and perhaps truly preventing — estrogen receptor [ER]–positive breast cancer in high-risk individuals."
http://www.cancer.gov